Today's Highlights
Premium
The Cubist Acquisition Inspires More Acquisitions. See Also: Xoma
Should we expect more acquisitions? Merck’s decision to acquire Cubist Pharmaceuticals (CBST) motivated investors in the biotechnology sector to look for other small antibiotic specialized firms that...
P
Prohost Biotech
1 min read
18
0
Unlock Premium Content
This article contains exclusive content for our premium subscribers. Join our community to access in-depth research, expert insights, and comprehensive analysis.
Unlimited articles
Expert analysis
Research reports
Tags
Comments (0)
Please sign in to join the discussion